Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

Analytical Tool - Angiogenesis in Oncology

BioSeeker Group AB
January 20, 2009
- Pub ID: BIOS2108789
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Related Reports


Executive Summary

"Analytical Tool - Angiogenesis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in anti-angiogenic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:

Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology Angiogenesis in Oncology: Drug Pipeline Update 2009*

The Package Includes A progress analysis on current and emerging drugs Information on most companies active in anti-angiogenic R&D in oncology Information on key industry related anti-angiogenic drug projects in oncology Data from most important clinical trials Information on early developmental stage projects Possibility of performing advanced searches suited to your individual needs This Tool will Assist You in:

Tracking cutting edge companies, therapies and new technologies Rapid identification of partners & competitors Laying down a comprehensive framework for further analysis of the field Producing presentations surrounding the development of anti-angiogenic drugs in oncology Identifying emerging apoptopic cancer products & key areas of pharmaceutical R&D

*BioSeeker’s CD-ROM searchable database reflects the most recent advances in the field of anti-angiogenic drug development for the treatment of cancer, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker Group CD-ROM searchable databases is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker Group’s CD-ROM searchable databases give better overview and specific search capabilities.

Related Reports:
Prostate Cancer Drug Discoveries: What the Future Holds
BI for Drug Development: Oracle Introduces Clinical Development Analytics
Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO)
Competitor Analysis: TGF-R Agonists and Antagonists
Competitor Analysis: FGF-R Agonists and Antagonists
Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis
Protein Kinase Therapeutics in Oncology - Where to Commercialize?
CDK Inhibitors Patent Landscape 2009
Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/22/2009 - 2